Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation-Reference-Cited by-同舟云学术

Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation

Published:2017-11-07 Issue:4 Volume:4 Page:328-329
ISSN:2058-5225
Container-title:European Heart Journal - Quality of Care and Clinical Outcomes
language:en
Short-container-title:

Author:

Coleman Craig I¹²,Weeda Erin R³,Nguyen Elaine⁴,Bunz Thomas J⁵,Sood Nitesh A⁶

Affiliation:

1. Department of Pharmacy Practice, University of Connecticut School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, Connecticut, USA

2. Evidence-Based Practice Center, Hartford Hospital, 80 Seymour Street, Hartford, CT, USA

3. Clinical Pharmacy and Outcome Sciences, Medical University of South Carolina College of Pharmacy, 171 Ashley Avenue, Charleston, SC, USA

4. Department of Pharmacy Practice, Idaho State University College of Pharmacy, 921 S. 8th Avenue, Stop 8288 , Pocatello, Idaho, USA

5. Department of Pharmacoepidemiology, New England Health Analytics, LLC, 54 Old Stagecoach Road, Granby, CT, USA

6. Department of Cardiac Electrophysiology, Southcoast Health System, Fall River, MA, USA

Funder

Bayer AG, Berlin

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

Link

http://academic.oup.com/ehjqcco/article-pdf/4/4/328/25948115/qcx044.pdf

Reference5 articles.

1. Heart disease and stroke statistics-2017 update: a report from the American Heart Association;Benjamin;Circulation,2017

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014

3. An automated database case definition for serious bleeding related to oral anticoagulant use;Cunningham;Pharmacoepidemiol Drug Saf,2011

4. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the rivaroxaban once daily, oral, direct factor xa inhibition compared with vitamin k antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF);Halperin;Circulation,2014

5. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study;Go;Ann Intern Med,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies;Current Medical Research and Opinion;2023-08-24

2. Efficacy and Safety of Oral Anticoagulants in Older Adult Patients With Atrial Fibrillation: Pairwise and Network Meta-Analyses;Journal of the American Medical Directors Association;2023-08

3. The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation;Rational Pharmacotherapy in Cardiology;2021-05-07

4. The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists;Cardiology Journal;2020-12-31

5. An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants?;Rational Pharmacotherapy in Cardiology;2020-12-30